Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of ageSummary of NACI statement of March 17, 2022. Post author By NACI Post date 5 April 2022 ← Initial Guidance on a Second Booster Dose of COVID-19 Vaccines in Canada → COVID-19 Vaccine Administration